Europe · Markets & Finance · Finanz und Wirtschaft

Novartis erhält für Rhapsido FDA-Zulassung bei weiterer Hautkrankheitsform

Published by Finanz und Wirtschaft · Switzerland 13 h ago

Die Zeitung für Wirtschaftsnachrichten, Hintergrund-Analysen, Währungs- und Börsenkurse sowie Anlageempfehlungen.

Read the full article on Finanz und Wirtschaft Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fuw.ch)

Also worth reading

Financial Times

Samsung quarterly profit surges to $80bn on AI chip demand

Cost of living squeeze over past five years has left working families £2,900 worse off, Resolution Foundation analysis shows

Retailers demand energy bill cuts as costs rise by £440m

Australian Dollar slips as Fed hike bets meet Middle East Oil risk

Reuters Markets

Porsche braces for era of lower sales as it leans in to luxury

Reuters Sustainability

European shares, euro fall as energy shock, fiscal worries bite